MindWalk Holdings Corp (HYFT)

Currency in USD
1.310
+0.030(+2.34%)
Closed·
1.250-0.060(-4.57%)
·
HYFT is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
1.2501.320
52 wk Range
0.9903.246
Key Statistics
Prev. Close
1.28
Open
1.29
Day's Range
1.25-1.32
52 wk Range
0.99-3.246
Volume
112.96K
Average Volume (3m)
369.43K
1-Year Change
-34.5%
Book Value / Share
0.17
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
HYFT Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
4.333
Upside
+230.79%
Members' Sentiments
Bearish
Bullish
ProTips
High shareholder yield

MindWalk Holdings Corp News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Neutral
Moving Averages
Neutral

Analyst Ratings

3 Buy
0 Hold
0 Sell
Ratings:
3 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 4.333
(+230.79% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
H.C. Wainwright
Buy5.00+281.68%-Maintain20-07-2026
H.C. Wainwright
Buy5.00+281.68%-Maintain02-07-2026
H.C. Wainwright
Buy5.00+281.68%-Maintain20-05-2026
Jones Trading
Buy5.00+281.68%-New Coverage15-04-2026
Benchmark
Buy3.00+129.01%3.00Maintain17-03-2026

MindWalk Holdings Corp Earnings Call Summary for Q4/2025

  • ImmunoPrecise reported record Q4 revenue of $7M, with gross margin improving to 64% from 48% YoY, despite a 14.74% stock price drop post-earnings
  • BioStrand segment grew 180% YoY, driven by increased interest in AI-driven preclinical drug development; company expects continued growth in this area
  • Company completing divestiture of Dutch subsidiary and rebranding to emphasize AI platform capabilities; anticipates revenue from oncology partnership in Q2
  • CEO Jennifer Bass highlighted positioning for 'earlier insights, stronger candidate selection, and faster decision making at scale' in drug development
  • Despite positive financials, stock fell sharply, potentially reflecting broader market concerns or undisclosed company-specific factors
Last Updated: 29-07-2025, 09:38 pm
Read Full Transcript

Earnings

Latest Release
15-12-2025
EPS / Forecast
-0.07 / --
Revenue / Forecast
4.12M / --
EPS Revisions
Last 90 days

HYFT Income Statement

Compare HYFT to Peers and Sector

Metrics to compare
HYFT
Peers
Sector
Relationship
P/E Ratio
−5.7x−12.0x−0.4x
PEG Ratio
−0.090.000.00
Price/Book
7.3x4.4x2.6x
Price / LTM Sales
5.5x7.2x3.1x
Upside (Analyst Target)
281.7%14.0%48.8%
Fair Value Upside
Unlock−2.0%5.7%Unlock

MindWalk Holdings Corp. operates as a bio-native AI company. The company discovers and develops biologics through HYFT Technology and LensAI platform, as well as develops AI drug discovery and biologics through ReefIQ technology. The company was formerly known as ImmunoPrecise Antibodies Ltd. and changed its name to MindWalk Holdings Corp. in September 2025. The company was incorporated in 1983 and is headquartered in Austin, Texas.

Employees
76

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
229.17K0.49%300.21K
Other Institutional Investors
4.51M9.60%5.91M
Public Companies & Retail Investors
42.25M89.92%55.35M
Total
46.99M100.00%61.55M

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Ingalls & Snyder, LLC6.19%29,07,0403,808
Susquehanna International Group, LLP1.14%5,34,016700

FAQ

What Is the MindWalk Holdings (HYFT) Share Price Today?

The MindWalk Holdings share price today is 1.310.

What is the current MindWalk Holdings (HYFT) share price and day range?

As of 09-08-2026, the MindWalk Holdings share price is 1.310, with a previous close of 1.280. The share price has ranged from 1.250 to 1.320 today, while the 52-week range spans from 0.990 to 3.246.

What Is the MindWalk Holdings Market Cap?

As of today, MindWalk Holdings market cap is 61.550M.

What Is the MindWalk Holdings (HYFT) Share Price Target?

The average 12-month share price target for MindWalk Holdings is 4.333, with a high estimate of 5 and a low estimate of 3. 3 analysts recommend buying, while 0 suggest selling, with an overall rating of Strong Buy and +230.79% Upside potential.

What Is MindWalk Holdings's Earnings Per Share (TTM)?

The MindWalk Holdings EPS (TTM) is -0.326.

From a Technical Analysis Perspective, Is HYFT a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

What Stock Exchange Does MindWalk Holdings Trade On?

MindWalk Holdings is listed and trades on the Nasdaq Stock Exchange.

What Is the Stock Symbol for MindWalk Holdings?

The stock symbol for MindWalk Holdings is "HYFT."

How Many Times Has MindWalk Holdings Stock Split?

MindWalk Holdings has split 1 times.

How Many Employees Does MindWalk Holdings Have?

MindWalk Holdings has 76 employees.

What Is the HYFT Premarket Price?

HYFT's last pre-market stock price is 1.300. The pre-market share volume is 1,310.000, and the stock has changed by 0.020, or 1.560%.

What Is the HYFT After Hours Price?

HYFT's last after hours stock price is 1.250, the stock has changed by -0.060, or -4.570%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.